CEO Brian Lian highlighted 2024 as an exceptionally busy year, with successful results from four studies, including the Phase 2 VENTURE trial for subcutaneous VK2735, which demonstrated up to 14.7% ...

Hello and thank you all for participating in today's call. Joining me today is Brian Lian, Viking's President and CEO; and Greg Zante, Viking's CFO. Before we begin, I'd like to caution that ...

I would now like to turn the conference over to Viking's Manager of Investor Relations, Stephanie Diaz. Please go ahead, Stephanie. Hello and thank you all for participating in today's call. Joining ...

Viking Therapeutics reports quarterly losses of ... an exciting and extremely productive year for Viking,” stated Brian Lian, Ph.D., CEO of Viking. “During the year, the company reported ...

2024 was an exciting and extremely productive year for Viking,” stated Brian Lian, Ph.D., chief executive ... TipRanks >> Read More on VKTX: Viking Therapeutics NewsMORE Related Stocks Indices ...

The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA. Read More on VKTX: Viking Therapeutics NewsMORE Related Stocks Indices ...